U.S. Physical Therapy (NYSE:USPH) Given New $108.00 Price Target at Barrington Research

U.S. Physical Therapy (NYSE:USPH) had its price objective reduced by Barrington Research from $122.00 to $108.00 in a research report sent to investors on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. Barrington Research also issued estimates for U.S. Physical Therapy’s Q4 2024 earnings at $0.66 EPS and Q4 2025 earnings at $0.75 EPS.

Separately, StockNews.com cut shares of U.S. Physical Therapy from a hold rating to a sell rating in a research note on Tuesday, August 13th. One analyst has rated the stock with a sell rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of Moderate Buy and a consensus price target of $112.50.

U.S. Physical Therapy Trading Up 1.3 %

Shares of USPH stock opened at $84.21 on Thursday. U.S. Physical Therapy has a 1-year low of $78.08 and a 1-year high of $113.63. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.88 and a quick ratio of 2.16. The business’s fifty day moving average price is $93.37 and its 200 day moving average price is $99.65. The firm has a market capitalization of $1.27 billion, a PE ratio of 68.46, a P/E/G ratio of 3.17 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH) last posted its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The firm had revenue of $167.19 million for the quarter, compared to analysts’ expectations of $163.34 million. During the same quarter in the previous year, the firm posted $0.76 earnings per share. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, sell-side analysts forecast that U.S. Physical Therapy will post 2.85 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Investors of record on Friday, August 23rd will be given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 2.09%. The ex-dividend date is Friday, August 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is 143.09%.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 2,900 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the transaction, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at $9,608,717.88. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CEO Christopher J. Reading sold 1,100 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $102.13, for a total value of $112,343.00. Following the completion of the transaction, the chief executive officer now directly owns 99,738 shares in the company, valued at $10,186,241.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Christopher J. Reading sold 2,900 shares of U.S. Physical Therapy stock in a transaction on Thursday, May 30th. The stock was sold at an average price of $100.26, for a total transaction of $290,754.00. Following the sale, the chief executive officer now directly owns 95,838 shares in the company, valued at approximately $9,608,717.88. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of institutional investors have recently made changes to their positions in USPH. Canada Pension Plan Investment Board acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth approximately $28,000. Innealta Capital LLC bought a new stake in U.S. Physical Therapy in the second quarter valued at $30,000. Quest Partners LLC lifted its stake in U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock valued at $32,000 after buying an additional 337 shares during the last quarter. Northwest Bank & Trust Co acquired a new position in shares of U.S. Physical Therapy during the fourth quarter valued at $37,000. Finally, SRS Capital Advisors Inc. grew its position in shares of U.S. Physical Therapy by 308.0% during the fourth quarter. SRS Capital Advisors Inc. now owns 408 shares of the company’s stock worth $38,000 after acquiring an additional 308 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.